Evidence map›Paper›PMID 36268930›Full record

ArticleMolecular imaging and radionuclide therapy2022

Mihoko Sasahara, Takashi Abe, Yoichi Otomi, Yumi Abe, Hiroaki Toba, Takayoshi Shinya, Hideki Otsuka, Masafumi Harada

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mihoko SasaharaTokushima University, Department of Radiology, Tokushima, Japan.ORCID 0000-0001-6855-7030
Takashi AbeNagoya University Hospital, Department of Radiology, Nagoya, Japan.ORCID 0000-0001-7325-8940
Yoichi OtomiTokushima University, Department of Radiology, Tokushima, Japan.ORCID 0000-0002-8960-3662
Yumi AbeNagoya University Hospital, Department of Radiology, Nagoya, Japan.ORCID 0000-0002-3881-0223
Hiroaki TobaTokushima University, Department of Thoracic and Endocrine Surgery and Oncology, Tokushima, Japan.ORCID 0000-0002-1914-3795
Takayoshi ShinyaTokushima University, Department of Radiology, Tokushima, Japan.ORCID 0000-0001-7101-5769
Hideki OtsukaTokushima University, Department of Radiology, Tokushima, Japan.ORCID 0000-0001-7165-6099
Masafumi HaradaTokushima University, Department of Radiology, Tokushima, Japan.ORCID 0000-0003-0958-1094
Tokushima University · JPNagoya University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing teratoma syndrome (GTS) is a condition in which poorly differentiated cells in a mixed-germ cell tumor (GCT) regress after chemotherapy, and the number of well-differentiated components increases. A 60-year-old man had an 8.0 cm mediastinal tumor with strong

Indexed as

18F-FDG PETgerm cell tumorGrowing teratoma syndromemediastinum

Identifiers

PMID36268930
PMCPMC9586005
OpenAlexW4306776642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.